SCHEMBL14459751

SCHEMBL14459751

CCc1ccc(C(=O)NC[C@@H](O)CO)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.54
TAS1R3 Q7RTX0 1/20 0.50
TAS1R1 Q7RTX1 1/20 0.50
ALDH1A1 P00352 8/20 0.49
HPGD P15428 3/20 0.49
KDM4E B2RXH2 1/20 0.49
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 4/20 0.46
MAPK1 P28482 1/20 0.46
NLRP1 Q9C000 1/20 0.46
NPSR1 Q6W5P4 1/20 0.44
TAOK1 Q7L7X3 2/20 0.44
TAOK3 Q9H2K8 2/20 0.44
GAA P10253 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPC1 O15118 1/20 0.43
POLB P06746 1/20 0.43
AGTR1 P30556 1/20 0.43
PRMT5 O14744 1/20 0.43
ACSS2 Q9NR19 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17208757 0.85 PLK1 (0.59) PLK1TAS1R3TAS1R1ALDH1A1HPGD
SCHEMBL13157814 0.83 LMNA (0.53) ALDH1A1HPGDKDM4ETDP1LMNA
SCHEMBL4979894 0.83 LMNA (0.53) ALDH1A1HPGDKDM4ETDP1LMNA
SCHEMBL12301897 0.83 LMNA (0.53) ALDH1A1HPGDKDM4ETDP1LMNA
SCHEMBL12332426 0.83 PLK1 (0.58) PLK1TAS1R3TAS1R1ALDH1A1HPGD
SCHEMBL10268332 0.81 HPGD (0.64) PLK1TAS1R3TAS1R1ALDH1A1HPGD
SCHEMBL12376591 0.81 EPHX2 (0.55) ALDH1A1HPGDKDM4ELMNAMAPK1
SCHEMBL12326089 0.81 PLK1 (0.54) PLK1TAS1R3TAS1R1ALDH1A1HPGD
SCHEMBL17845263 0.80 PLK1 (0.50) PLK1TAS1R3TAS1R1ALDH1A1HPGD
SCHEMBL24227433 0.80 PRMT5 (0.57) ALDH1A1HPGDKDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ARRAY BIOPHARMA, INC. 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ERBB2, LCK, SRC PLK1 603/4885TAS1R3 1916/4885TAS1R1 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.